The absence of Angiotensin II receptors and ACE in canine mitral valve leaflets suggests the renin-angiotensin system is not a major driver of myxomatous valvular changes.
Answers are grounded in this paper and cite their sources.
Suggests RAS-independent mechanisms predominate in canine myxomatous valve disease; leaves open translational relevance to other species or humans.
The renin-angiotensin system, including angiotensin (Ang) II and angiotensin-converting enzyme (ACE), plays an important role in cardiac fibrous tissue formation. Since changes in valvular collagen are a central part of myxomatous mitral valve disease in the dog, we speculated that Ang II and ACE might play a role in the pathogenesis of this disease. In 10 mitral valves, five with and five without clear myxomatous changes, the presence and distribution of Ang II receptors and ACE was examined autoradiographically, using 125I-Ang II and 125I-lisinopril, respectively. At postmortem examination, diseased valves were taken from old dogs, control valves from young adult dogs. No significant level of Ang II and lisinopril binding was found in normal as well as diseased valve leaflets. Equally low, insignificant levels of 125I-Ang II binding were found in the myocardium of dogs with and without valvular disease. No significant level of myocardial 125I-lisinopril binding was found. The lack of autoradiographic evidence of Ang II receptors and ACE in normal and diseased canine mitral valve leaflets suggests that the renin-angiotensin system does not play a major role in the pathogenesis of the valvular changes.
No takes yet. Share an insight, caveat, or question.
Mow et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: